The Healthcare Commercialization Journey – Stories from entrepreneurs who have been there, or are on their way
from Thursday, April 12, 2018 3:00PM to Thursday, April 12, 2018 7:00PM
Ticket Information
Event Details
Successful innovation in healthcare requires navigating a long and challenging journey. It takes dedication, time and ultimately perseverance to forge into the unknown and disrupt the healthcare industry. Join us at JLABS @ Toronto to hear from a variety of panels with life science entrepreneurs who will discuss their technology, journey and successes. Panels: From Research to Incorporation It is important to translate healthcare innovations from academia into commercialization. It is up to the scientists and graduate students to move scientific discoveries from the lab to market. Hear from three entrepreneurs who started their companies in a hospital or academic lab and why they chose to incorporate. Panelists: Sean Kidd, Co-founder, A4i; Roderick Slavcev, CEO, Mediphage Bioceuticals; Christine Allen, Co-founder & President, Nanovista Moderator: Allan Miranda, Head, JLABS Canada Getting Closer to Commercialization in Biotech A new partnership, a Series A raised and a 510k clearance – the last year for these three companies has been significant. Let’s explore how they got where they are and where they’re going next. Panelists: Chris Barden, CEO, Treventis Corporation; Michael Scott, Sr. Vice President, Product Development & Toronto Operations, BlueRock Therapeutics; Lionel Lenkinski, CEO, NerveVision Moderator: Rebecca Yu, Vice President, Market Access & External Affairs, Takeda Canada Inc. Launching a Consumer Health Product Today, we are taking an increasingly active role in managing our own health. As a result, the demand for consumer healthcare products is growing. These start-ups took advantage of market trends and developed products all of which are currently for sale. Learn how they navigated the road to retail and brought their consumer health products to market. Panelists: Ted Jin, CEO, Dosebiome; Jessica Ching, Co-founder & CEO, Eve Medical; Andrew Martinko, Co-founder & CEO, Suncayr Moderator: Stefanie Dhanda, Senior Director, Scientific Innovation, Consumer, Johnson & Johnson Innovation Commercializing Artificial Intelligence Artificial intelligence (AI) poses unlimited opportunity for us to make a transformative impact on patients. AI could save scientists valuable research time and bring new treatments to patients more quickly. Learn how these three companies are driving the adoption and commercialization of AI technologies through their work. Panelists: Naheed Kurji, CEO, Cyclica; Shelley Boyd, CEO, Tracery Ophthalmics; Liam Kaufman, CEO, Winterlight Labs Moderator:To be announced! Agenda 4:00pm | Registration 4:15pm | Panel 1: From Research to Incorporation 4:55pm | Panel 2: Getting Closer to Commercialization in Biotech 5:35pm | Break 5:45pm | Panel 3: Launching a Consumer Health Product 6:25pm | Panel 4: Commercializing Artificial Intelligence 7:00pm | Networking 8:00pm | Program Close Fees FREE | General Public Location JLABS @ Toronto 661 University Ave, Suite 1300 Toronto, Ontario
JLABS @ Toronto
661 University Ave Toronto ON CAType: Eventbrite